EBV BALF-4 276-284 (HLA-A*02:01)

€50.00 *

Delivery time 2-3 days
sterile and endotoxin free Delivery Format:
The product is supplied freeze dried as trifluoracetate salt

Order number: EP11237_1

FLDKGTYTL is a linear peptidic epitope (epitope ID16548) studied as part of Envelope glycoprotein... more

Close menu

Product information "EBV BALF-4 276-284 (HLA-A*02:01)"

FLDKGTYTL is a linear peptidic epitope (epitope ID16548) studied as part of Envelope glycoprotein B from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays Antigen Peptide EBV BALF-4 276ï¾–284 (HLA-A*02:01) FLDKGTYTL for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.FLDKGTYTL is a linear peptidic epitope (epitope ID16548) studied as part of Envelope glycoprotein B from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays Antigen Peptide EBV BALF-4 276ï¾–284 (HLA-A*02:01) FLDKGTYTL for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Zurück

Sequence:	FLDKGTYTL
Gene:	BALF4
Delivery:	2-3 days
C-Terminus:	OH
N-Terminus:	H
Purity:	95%
Amount:	1 mg
Counter Ion:	TFA
Protein:	Envelope glycoprotein B
Species:	EBV
Allele:	HLA-A*02:01
Application :	Flow Cytometry
Indication :	Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma